3H5 Stock Overview
An investment holding company, provides healthcare services for women and children in Singapore and Malaysia. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 2/6 |
| Past Performance | 1/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Thomson Medical Group Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | S$0.032 |
| 52 Week High | S$0.04 |
| 52 Week Low | S$0.032 |
| Beta | 0.77 |
| 11 Month Change | -1.54% |
| 3 Month Change | -1.54% |
| 1 Year Change | -12.33% |
| 33 Year Change | -37.25% |
| 5 Year Change | -13.51% |
| Change since IPO | -8.57% |
Recent News & Updates
Recent updates
Shareholder Returns
| 3H5 | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | 0% | 1.1% | 0.2% |
| 1Y | -12.3% | 16.5% | 8.5% |
Return vs Industry: 3H5 underperformed the German Healthcare industry which returned 16.5% over the past year.
Return vs Market: 3H5 underperformed the German Market which returned 8.5% over the past year.
Price Volatility
| 3H5 volatility | |
|---|---|
| 3H5 Average Weekly Movement | 3.6% |
| Healthcare Industry Average Movement | 4.1% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.9% |
| 10% least volatile stocks in DE Market | 2.3% |
Stable Share Price: 3H5 has not had significant price volatility in the past 3 months compared to the German market.
Volatility Over Time: 3H5's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1979 | 2,131 | Melvin Heng | www.thomsonmedical.com |
Thomson Medical Group Limited, an investment holding company, provides healthcare services for women and children in Singapore and Malaysia. It operates in Hospital Services and Specialised Services segments. The company owns and operates the Thomson Medical Centre, as well as a network of 37 clinics and centers that provide integrated medical healthcare facilities and services, such as obstetrics, gynaecology, paediatric, diagnostic imaging, pharmacy, 24-hour outpatient, laboratory, health screening, gynaecological oncology, dentistry, musculoskeletal and sports medicine, and medical aesthetics services, as well as counselling and specialised learning services for children with learning difficulties; and services provided by the fertility clinics, paediatric centres, cancer centres, cardiology centres, traditional Chinese medicine, specialist skin centre services.
Thomson Medical Group Limited Fundamentals Summary
| 3H5 fundamental statistics | |
|---|---|
| Market cap | €885.20m |
| Earnings (TTM) | €10.99m |
| Revenue (TTM) | €253.57m |
80.5x
P/E Ratio3.5x
P/S RatioIs 3H5 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 3H5 income statement (TTM) | |
|---|---|
| Revenue | S$355.98m |
| Cost of Revenue | S$196.99m |
| Gross Profit | S$159.00m |
| Other Expenses | S$143.56m |
| Earnings | S$15.44m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.00058 |
| Gross Margin | 44.66% |
| Net Profit Margin | 4.34% |
| Debt/Equity Ratio | 191.3% |
How did 3H5 perform over the long term?
See historical performance and comparison